Catalyst Wire Dossier Catalyst Wire Dossier

OXP001(2)

· Oxford Pharmascience Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OXP001(2), covering 2015-10-28 to 2015-10-28. Get the full timeline:

Most recent: Clinical Trial Update: Pilot Study of OXP001(2) and Brufen in Healthy Subjects [Phase 1]

See pricing